SweetValueLab
Write for us

The Cooper Companies, Inc. — Financial Statements & Ratios

COO
NASDAQHealthcareMedical - Instruments & SuppliesCIK 0000711404coopercos.comAbout COO
Last close · Oct 16, 202657.94+0.54 (+0.94%)
Market cap$11.0B

Key indicators

Revenue4.2BTTM+4.7% on a year earlier+7.1% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
2.5B 2.7B+4.8%2.4B−8.4%2.9B+20.2%3.3B+13.2%3.6B+8.6%3.9B+8.4%4.1B+5.1%4.2B+4.7%4.2B 4.4B 4.6B
— 4.8% -8.4% 20.2% 13.2% 8.6% 8.4% 5.1% 4.7% 3.6% 4.0% 4.9%
$0.70 $2.33+232.0%$1.20−48.4%$14.79+1129.9%$1.94−86.9%$1.48−23.8%$1.96+32.7%$1.87−4.6%$2.92+43.1%$4.54 $4.70 $5.11
Profitability
64.4% 66.2%+1.8 pt63.1%−3.1 pt66.9%+3.8 pt64.7%−2.3 pt65.6%+0.9 pt66.6%+1.0 pt65.5%−1.1 pt65.9%−1.0 pt· · ·
15.9% 20.6%+4.7 pt12.8%−7.8 pt17.3%+4.5 pt15.3%−2.0 pt14.8%−0.5 pt18.1%+3.3 pt16.7%−1.4 pt12.8%−5.5 pt· · ·
5.5% 17.6%+12.1 pt9.8%−7.8 pt100.8%+91.0 pt11.7%−89.1 pt8.2%−3.5 pt10.1%+1.9 pt9.2%−0.9 pt13.5%+3.4 pt· · ·
4.2% 12.9%+8.6 pt6.2%−6.6 pt42.4%+36.2 pt5.4%−37.0 pt3.9%−1.5 pt4.9%+1.0 pt4.6%−0.3 pt— · · ·
Cash
475.3M 421.1M−11.4%176.2M−58.2%524.2M+197.5%450.4M−14.1%215.0M−52.3%288.1M+34.0%433.7M+50.5%678.0M+64.6%· · ·
18.8% 15.9%−2.9 pt7.2%−8.6 pt17.9%+10.7 pt13.6%−4.3 pt6.0%−7.6 pt7.4%+1.4 pt10.6%+3.2 pt16.0%+5.8 pt· · ·
2.9M 3.0M+3.4%3.0M+0.0%3.0M+0.0%3.0M+0.0%3.0M+0.0%0−100.0%0 — · · ·
Balance sheet
0.61x 0.50x−0.11x0.47x−0.03x0.21x−0.26x0.38x+0.17x0.34x−0.04x0.32x−0.02x0.30x−0.02x0.31x+0.01x· · ·
198.80M 200.00M+0.6%198.40M−0.8%199.20M+0.4%198.80M−0.2%199.20M+0.2%200.40M+0.6%200.00M−0.2%193.40M−3.3%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jul 31, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period. EPS and share counts before a stock split are restated in today's share terms.